This HTML5 document contains 186 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n5	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n3	http://linked.opendata.cz/ontology/sukl/
n18	http://linked.opendata.cz/resource/sukl/specialization-restriction/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0111831/price-of-originator/
skos	http://www.w3.org/2004/02/skos/core#
n10	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0111831/reimbursement/
n8	http://linked.opendata.cz/resource/sukl/indgroup/
n12	http://linked.opendata.cz/resource/sukl/packing/
n20	http://linked.opendata.cz/resource/sukl/company/
n11	http://linked.opendata.cz/resource/sukl/active-ingredient/
n9	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0111831/
n14	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0111831/core-reimbursement/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n16	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0111831/price/
n15	http://linked.opendata.cz/resource/sukl/registration-state/
xsdh	http://www.w3.org/2001/XMLSchema#
n6	http://www.sukl.cz/modules/medication/
n19	http://linked.opendata.cz/resource/atc/
n7	http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item

n2:0111831

rdf:type

n3:MedicinalProductPackaging

dcterms:title

KVENTIAX 150 MG POTAHOVANÉ TABLETY

skos:notation

0111831

n3:hasATCCode

n19:N05AH04

n3:hasActiveIngredient

n11:QUETIAPINI-FUMARAS

n3:hasDefinedDailyDose

n9:ddd

n3:hasDosageForm

n7:TBL-FLM-POR

n3:hasPackagingSize

30

n3:hasPacking

n12:BLI

n3:hasRegistrationHolder

n20:KRKSLO

n3:hasRegistrationState

n15:R

n3:hasRouteOfAdministration

n5:POR

n3:hasStrength

150MG

n3:hasIndicationGroup

n8:68

n3:hasSpecializationRestriction

n18:PSY

n3:containsDefinedDailyDoses

11.25

n3:hasRegistrationCode

68/ 474/07-C

n3:hasTitleSupplement

POR TBL FLM 30X150MG

n3:containsUsualTherapeuticalDailyDoses

11.25

n3:hasBreakMarketingDate

2011-12-22+01:00

n3:hasCoreReimbursementSpecification

n14:2013-01-01 n14:2013-01-05 n14:2013-04-01 n14:2013-05-01 n14:2013-02-01 n14:2013-03-01 n14:2013-08-01 n14:2013-08-03 n14:2013-06-01 n14:2013-07-01 n14:2013-11-01 n14:2013-12-01 n14:2013-09-01 n14:2013-10-01 n14:2014-03-01 n14:2014-04-01 n14:2014-01-01 n14:2014-02-01 n14:2014-06-13 n14:2014-07-01 n14:2014-05-01 n14:2014-06-01 n14:2014-09-01 n14:2014-10-01 n14:2014-07-03 n14:2014-08-01 n14:2014-11-19 n14:2014-12-01 n14:2014-10-02 n14:2014-11-01 n14:2015-02-01 n14:2015-03-01 n14:2015-01-01 n14:2015-01-13 n14:2015-05-01 n14:2015-06-01 n14:2015-04-01 n14:2015-04-02 n14:2015-07-01 n14:2015-07-02

n3:hasIndicationRestriction

P

n3:hasPriceOfOriginatorSpecification

n4:2014-07-03 n4:2014-08-01 n4:2014-06-13 n4:2014-07-01 n4:2014-05-01 n4:2014-06-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2013-11-01 n4:2013-12-01 n4:2013-09-01 n4:2013-10-01 n4:2013-08-01 n4:2013-08-03 n4:2013-06-01 n4:2013-07-01 n4:2013-04-01 n4:2013-05-01 n4:2013-02-01 n4:2013-03-01 n4:2013-01-01 n4:2013-01-05 n4:2015-07-01 n4:2015-07-02 n4:2015-05-01 n4:2015-06-01 n4:2015-04-01 n4:2015-04-02 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13 n4:2014-11-19 n4:2014-12-01 n4:2014-10-02 n4:2014-11-01 n4:2014-09-01 n4:2014-10-01

n3:hasPriceSpecification

n16:2015-07-01 n16:2015-07-02 n16:2015-01-01 n16:2015-01-13 n16:2015-02-01 n16:2015-03-01 n16:2015-04-01 n16:2015-04-02 n16:2015-05-01 n16:2015-06-01 n16:2014-07-03 n16:2014-08-01 n16:2014-09-01 n16:2014-10-01 n16:2014-10-02 n16:2014-11-01 n16:2014-11-19 n16:2014-12-01 n16:2014-01-01 n16:2014-02-01 n16:2014-03-01 n16:2014-04-01 n16:2014-05-01 n16:2014-06-01 n16:2014-06-13 n16:2014-07-01 n16:2013-06-01 n16:2013-07-01 n16:2013-08-01 n16:2013-08-03 n16:2013-09-01 n16:2013-10-01 n16:2013-11-01 n16:2013-12-01 n16:2013-01-01 n16:2013-01-05 n16:2013-02-01 n16:2013-03-01 n16:2013-04-01 n16:2013-05-01

n3:hasReimbursementSpecification

n10:2015-07-01 n10:2015-07-02 n10:2015-02-01 n10:2015-03-01 n10:2015-01-01 n10:2015-01-13 n10:2015-05-01 n10:2015-06-01 n10:2015-04-01 n10:2015-04-02 n10:2014-09-01 n10:2014-10-01 n10:2014-07-03 n10:2014-08-01 n10:2014-11-19 n10:2014-12-01 n10:2014-10-02 n10:2014-11-01 n10:2014-03-01 n10:2014-04-01 n10:2014-01-01 n10:2014-02-01 n10:2014-06-13 n10:2014-07-01 n10:2014-05-01 n10:2014-06-01 n10:2013-08-01 n10:2013-08-03 n10:2013-06-01 n10:2013-07-01 n10:2013-11-01 n10:2013-12-01 n10:2013-09-01 n10:2013-10-01 n10:2013-01-01 n10:2013-01-05 n10:2013-04-01 n10:2013-05-01 n10:2013-02-01 n10:2013-03-01

n3:hasResumedMarketingDate

2010-12-20+01:00 2013-08-26+02:00

n3:hasUsualTherapeuticalDailyDose

n9:utdd

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC56478.pdf%26type%3Dspc%26as%3Dkventiax-150-mg-potahovane-tablety-spc

n3:spcUri

n6:download.php?file=SPC56478.pdf&type=spc&as=kventiax-150-mg-potahovane-tablety-spc